Empowering Pharmacists in the Fight Against Opioid Abuse Act
(Sec. 2) This bill requires the Department of Health and Human Services (HHS) to develop and disseminate training programs and materials on: (1) the circumstances under which a pharmacist may refuse to fill a controlled substance prescription suspected to be fraudulent, forged, or indicative of abuse or diversion; and (2) federal requirements related to such refusal.
HHS must seek input from relevant stakeholders.
[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4275 Introduced in House (IH)]
<DOC>
115th CONGRESS
1st Session
H. R. 4275
To provide for the development and dissemination of programs and
materials for training pharmacists, health care providers, and patients
on indicators that a prescription is fraudulent, forged, or otherwise
indicative of abuse or diversion, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
November 7, 2017
Mr. DeSaulnier (for himself and Mr. Carter of Georgia) introduced the
following bill; which was referred to the Committee on Energy and
Commerce
_______________________________________________________________________
A BILL
To provide for the development and dissemination of programs and
materials for training pharmacists, health care providers, and patients
on indicators that a prescription is fraudulent, forged, or otherwise
indicative of abuse or diversion, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Empowering Pharmacists in the Fight
Against Opioid Abuse Act''.
SEC. 2. PROGRAMS AND MATERIALS FOR TRAINING ON CERTAIN CIRCUMSTANCES
UNDER WHICH A PHARMACIST MAY DECLINE TO FILL A
PRESCRIPTION.
(a) In General.--Not later than 1 year after the date of enactment
of this Act, the Administrator of the Drug Enforcement Administration,
in consultation with the Secretary of Health and Human Services, the
Commissioner of Food and Drugs, the Director of the Centers for Disease
Control and Prevention, and the Assistant Secretary for Mental Health
and Substance Use, shall develop and disseminate programs and materials
for training pharmacists, health care providers, and patients on--
(1) circumstances under which a pharmacist may, consistent
with section 201 of the Controlled Substances Act (21 U.S.C.
811) and regulations thereunder, including section 1306.04 of
title 21, Code of Federal Regulations, decline to fill a
prescription for a controlled substance because the pharmacist
suspects the prescription is fraudulent, forged, or otherwise
indicative of abuse or diversion; and
(2) any Federal requirements pertaining to declining to
fill a prescription under such circumstances.
(b) Materials Included.--In developing materials under subsection
(a), the Administrator of the Drug Enforcement Administration shall
include information educating--
(1) pharmacists on how to decline to fill a prescription
and actions to take after declining to fill a prescription; and
(2) other health care practitioners and the public on a
pharmacist's responsibility to decline to fill prescriptions in
certain circumstances.
(c) Stakeholder Input.--In developing the programs and materials
required under subsection (a), the Administrator of the Drug
Enforcement Administration shall seek input from relevant national,
State, and local associations, boards of pharmacy, medical societies,
licensing boards, health care practitioners, and patients.
<all>
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Subcommittee Consideration and Mark-up Session Held.
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Committee Consideration and Mark-up Session Held.
Ordered to be Reported (Amended) by Voice Vote.
Mr. Walden moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H5066-5067)
DEBATE - The House proceeded with forty minutes of debate on H.R. 4275.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5066)
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5066)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.